查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1548075

全球疫苗市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 222 Pages | 商品交期: 最快1-2個工作天內

價格

全球疫苗市場需求預計將從2023年的1,274.1億美元達到2032年近1,591.1億美元的市場規模，2024-2032年研究期間複合年成長率為2.5%。

疫苗是透過產生針對特定疾病的免疫力來保護人們免受疾病侵害的物質。它含有死亡或弱化的微生物；這些微生物刺激免疫系統產生抗體。大多數疫苗透過注射、鼻腔或口腔注射。根據用於活化或刺激免疫系統的策略，疫苗分為不同類型：去活化疫苗、減毒疫苗、類毒素疫苗、次單位疫苗、實驗疫苗、價疫苗、異型疫苗和合併疫苗。有許多疫苗正在開發中，尚未商業化。

市場動態

預計全球根除目標和人口擴張將推動疫苗市場的成長。每年，估計有 200-300 萬兒童死亡和 60 萬成人死亡透過疫苗接種得到預防。儘管如此，仍有許多疾病每年奪走數百萬人的生命，而且目前還沒有有效的疫苗，這促使人們對新的和改進的疫苗進行研究和開發。高收入國家是疫苗的主要購買國，佔全球疫苗銷售量的 82%。然而，疫苗浪費被認為是影響市場收入的一個主要問題。還有一個擔憂是，一些國家沒有足夠的資金購買疫苗，而一些國家由於國家當局運作不善而沒有進行疫苗開發所需的資源或授權。這會影響疫苗未來的可行性。為了評估這些影響成長的因素，世衛組織正在採取各種措施，開發一套工具來支持規劃和合作夥伴衡量和解決疫苗接種不足問題。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球疫苗市場的各個細分市場進行了包容性評估。疫苗產業的成長和趨勢為本研究提供了整體方法。

市場區隔

疫苗市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按類型

  • 次單位疫苗（重組疫苗、結合疫苗、類毒素疫苗）
  • 去活化
  • 活衰減
  • mRNA疫苗
  • 病毒載體疫苗

依給藥途徑

  • 口服
  • 注射用
  • 鼻腔

按疾病適應症

  • 病毒性疾病（肝炎、流感、HPV、MMR、輪狀病毒、帶狀皰疹、Covid-19 等）
  • 細菌疫苗（腦膜炎雙球菌病、肺炎球菌病、百白破、其他）
  • 癌症疫苗
  • 過敏疫苗

按年齡段

  • 兒科
  • 成人

按配銷通路

  • 醫院和零售藥房
  • 政府供應商
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲疫苗市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。疫苗市場的主要參與者包括印度血清研究所 Pvt。 Ltd.、Seqirus、賽諾菲、GSK Plc.、默克公司、輝瑞公司、Moderna Inc.、科興、BioNTech SE、阿斯特捷利康。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：疫苗 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按給藥途徑進行的市場吸引力分析
    • 依疾病適應症進行的市場吸引力分析
    • 按年齡層別分類的市場吸引力分析
    • 按配銷通路分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球疫苗市場分析：按類型

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 次單位疫苗（重組疫苗、結合疫苗、類毒素疫苗）
  • 去活化
  • 活衰減
  • mRNA疫苗
  • 病毒載體疫苗

第 6 章：全球疫苗市場分析：依給藥途徑

  • 依給藥途徑概述
  • 歷史和預測數據
  • 依給藥途徑分析
  • 口服
  • 注射用
  • 鼻腔

第 7 章：全球疫苗市場分析：按疾病適應症

  • 按疾病適應症概述
  • 歷史和預測數據
  • 按疾病指徵分析
  • 病毒性疾病（肝炎、流感、HPV、MMR、輪狀病毒、帶狀皰疹、Covid-19 等）
  • 細菌疫苗（腦膜炎雙球菌病、肺炎球菌病、百白破、其他）
  • 癌症疫苗
  • 過敏疫苗

第 8 章：全球疫苗市場分析：依年齡層別分類

  • 按年齡層別概覽
  • 歷史和預測數據
  • 按年齡層分析
  • 兒科
  • 成人

第 9 章：全球疫苗市場分析：按分銷管道

  • 配銷通路概述
  • 歷史和預測數據
  • 按配銷通路分析
  • 醫院和零售藥房
  • 政府供應商
  • 其他

第 10 章：全球疫苗市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 11 章：疫苗公司的競爭格局

  • 疫苗市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 12 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Serum Institute Of India Pvt. Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Seqirus
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sanofi
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • GSK Plc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Merck & Co. Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Pfizer Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Moderna Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sinovac
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BioNTech SE
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • AstraZeneca
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11211825

The global demand for Vaccine Market is presumed to reach the market size of nearly USD 159.11 Billion by 2032 from USD 127.41 Billion in 2023 with a CAGR of 2.5% under the study period 2024-2032.

Vaccines are the substance that protects people from diseases by producing immunity to a specific disease. It contains a dead or weakened version of microbes; these microbes stimulate immune system to produce antibodies. Most vaccines are given by injection, nasally, or by mouth. Depending on strategies utilised to activate or stimulate immune system,vaccines are classified into different types:inactivated, attenuated, toxoid, subunit, experimental, valence, heterotypic and conjugate. There are number of the vaccines under development and yet to commercialise.

MARKET DYNAMICS

Global eradication goals and population expansion are predicted to drive the growth of the vaccine market. Annually, an estimated 2-3 million child deaths and 600,000 adult deaths are prevented by vaccination. Still, there are many diseases that claim millions of lives yearly and for which effective vaccines are not yet available this is giving rise to research and development of the new and improved vaccine. High-income countries are major purchasers of vaccine constituting 82% of global vaccine sales. However, vaccine wastage is identified as a major problem to affect market revenue. There is also another concern that some countries have insufficient funds to buy vaccine while some countries don't have resource or mandate required to conduct the vaccine development due to poor functioning national authorities. This affects the future viability of the vaccine. To assess these factors affecting growth, WHO is taking various measures by developing a set of tools to support programmes and partners to measure and address under-vaccination.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Vaccine. The growth and trends of Vaccine industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Vaccine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines)
  • Inactivated
  • Live Attenuated
  • mRNA vaccines
  • Viral vector vaccines

By Route of Administration

  • Oral
  • Parenteral
  • Nasal

By Disease Indication

  • Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others)
  • Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others)
  • Cancer Vaccines
  • Allergy Vaccines

By Age Group

  • Pediatric
  • Adult

By Distribution Channel

  • Hospital & Retail Pharmacies
  • Government Suppliers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Vaccine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Vaccine market include Serum Institute Of India Pvt. Ltd., Seqirus, Sanofi, GSK Plc., Merck & Co. Inc., Pfizer Inc., Moderna Inc., Sinovac, BioNTech SE, AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. VACCINE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Disease Indication
    • 3.7.4 Market Attractiveness Analysis By Age Group
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL VACCINE MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Type
  • 5.4. Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines) Historic and Forecast Sales By Regions
  • 5.5. Inactivated Historic and Forecast Sales By Regions
  • 5.6. Live Attenuated Historic and Forecast Sales By Regions
  • 5.7. mRNA vaccines Historic and Forecast Sales By Regions
  • 5.8. Viral vector vaccines Historic and Forecast Sales By Regions

6. GLOBAL VACCINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route of Administration
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Route of Administration
  • 6.4. Oral Historic and Forecast Sales By Regions
  • 6.5. Parenteral Historic and Forecast Sales By Regions
  • 6.6. Nasal Historic and Forecast Sales By Regions

7. GLOBAL VACCINE MARKET ANALYSIS BY DISEASE INDICATION

  • 7.1. Overview By Disease Indication
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Disease Indication
  • 7.4. Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Historic and Forecast Sales By Regions
  • 7.5. Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Historic and Forecast Sales By Regions
  • 7.6. Cancer Vaccines Historic and Forecast Sales By Regions
  • 7.7. Allergy Vaccines Historic and Forecast Sales By Regions

8. GLOBAL VACCINE MARKET ANALYSIS BY AGE GROUP

  • 8.1. Overview By Age Group
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Age Group
  • 8.4. Pediatric Historic and Forecast Sales By Regions
  • 8.5. Adult Historic and Forecast Sales By Regions

9. GLOBAL VACCINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1. Overview By Distribution Channel
  • 9.2. Historical and Forecast Data
  • 9.3. Analysis By Distribution Channel
  • 9.4. Hospital & Retail Pharmacies Historic and Forecast Sales By Regions
  • 9.5. Government Suppliers Historic and Forecast Sales By Regions
  • 9.6. Others Historic and Forecast Sales By Regions

10. GLOBAL VACCINE MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE VACCINE COMPANIES

  • 11.1. Vaccine Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF VACCINE INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Serum Institute Of India Pvt. Ltd.
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Seqirus
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Sanofi
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. GSK Plc.
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. Merck & Co. Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Pfizer Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Moderna Inc.
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Sinovac
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. BioNTech SE
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. AstraZeneca
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines) Market Sales By Geography (USD MN)
  • Inactivated Market Sales By Geography (USD MN)
  • Live Attenuated Market Sales By Geography (USD MN)
  • mRNA vaccines Market Sales By Geography (USD MN)
  • Viral vector vaccines Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Nasal Market Sales By Geography (USD MN)
  • Analysis By Disease Indication (USD MN)
  • Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Market Sales By Geography (USD MN)
  • Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Market Sales By Geography (USD MN)
  • Cancer Vaccines Market Sales By Geography (USD MN)
  • Allergy Vaccines Market Sales By Geography (USD MN)
  • Analysis By Age Group (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital & Retail Pharmacies Market Sales By Geography (USD MN)
  • Government Suppliers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Vaccine Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Vaccine Report
  • Market Research Process
  • Market Research Methodology
  • Global Vaccine Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Disease Indication
  • Market Attractiveness Analysis By Age Group
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines) Market Sales By Geography (USD MN)
  • Inactivated Market Sales By Geography (USD MN)
  • Live Attenuated Market Sales By Geography (USD MN)
  • mRNA vaccines Market Sales By Geography (USD MN)
  • Viral vector vaccines Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Nasal Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Indication (USD MN)
  • Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Market Sales By Geography (USD MN)
  • Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Market Sales By Geography (USD MN)
  • Cancer Vaccines Market Sales By Geography (USD MN)
  • Allergy Vaccines Market Sales By Geography (USD MN)
  • Global Market Analysis By Age Group (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital & Retail Pharmacies Market Sales By Geography (USD MN)
  • Government Suppliers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.